The European Pregnancy Testing Market size was worth USD 0.28 Billion in 2020 and estimated to reach USD 0.36 Billion by 2025, growing at a CAGR of 5.06% between 2020 to 2025.
Pregnancy tests are tests used to detect reproductive hormones such as Follicle Stimulating Hormone or Luteinising Hormone. Fertility rapid test kits help determine the exact day of ovulation or confirm the presence of menopause in women, whereas they are used to detect the sperm count.
European Market for Pregnancy and fertility devices is mainly driven by rising demand for fast and independent tests, increasing prevalence of infertility and gynecological disorders, accessibility of decentralized diagnostic tests over time-consuming laboratory tests. Technological advancements and striking product features, and escalating first-time pregnancy age are factors that boost the growth of the Pregnancy and fertility devices market.
However, the low adaptation rate and the high price of test kits are the major factors restraining the market's growth.
This research report on the European Pregnancy Testing Market has been segmented and sub-segmented into the following categories:
By Product:
By Test Type:
By Distribution Channel:
By Country:
The geographical European market for pregnancy testing is analyzed under five major regions: the United Kingdom, Germany, Italy, Spain, and France. Europe is the second-largest market for Pregnancy and fertility devices. Within Europe, the United Kingdom accounted for the largest share of the Pregnancy testing market, while Germany is the fastest-growing segment.
Companies playing a key role in the European Pregnancy Testing Market are Abbott Laboratories, Cardinal Health, Church & Dwight, Germaine Laboratories, Kent Pharmaceuticals, Piramal Enterprises, Prestige Brands Holdings, Procter & Gamble Co., Quidel Corporation, and SPD Swiss Precision Diagnostics.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Pregnancy Test Kits
5.1.1.1 Strips/Dip Sticks & Cards
5.1.1.2 Mid-Stream
5.1.1.3 Cassette
5.1.1.4 Digital Devices
5.1.2 Ovulation/Fertility Test Kits
5.1.2.1 Line Indicator Devices
5.1.2.2 Digital Devices
5.2 By Test Type
5.2.1 FSH Urine Test
5.2.2 Luteinizing Hormone (LH) Urine Test
5.2.3 Human Chorionic Gonadotropin (hCG) Hormone Blood Test
5.2.4 Human Chorionic Gonadotropin (hCG) Hormone Urine Test
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alere Inc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Quidel Corporation
8.3 Prestige Brands Holdings
8.4 Church & Dwight Co
8.5 bioMérieux SA
8.6 Geratherm Medical AG
8.7 Germaine Laboratories
8.8 Abbott Laboratories
8.9 Kent Pharmaceuticals
8.10 Rite-Aid
8.11 Procter & Gamble Co.
8.12 DCC Plc.
8.13 Swiss Precision Diagnostics GmbH
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
